These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6166477)

  • 1. Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin-release in vitro and in vivo. Protease inhibitors and trypsin-induced bradykinin release.
    Balldin G; Gustafsson EL; Ohlsson K
    Eur Surg Res; 1980; 12(4):260-9. PubMed ID: 6166477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trasylol prevents trypsin-induced shock in dogs.
    Balldin G; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):651-6. PubMed ID: 89067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
    Lasson A; Dittmann B; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
    Lasson A; Ohlsson K
    Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro.
    Balldin G; Ohlsson K; Olsson AS
    Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):691-7. PubMed ID: 307526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of alpha 2-macroglobulin and aprotinin.
    Ohlsson F; Balldin G; Lasson A
    Adv Exp Med Biol; 1983; 156 (Pt B)():1083-90. PubMed ID: 6190382
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions in vitro and in vivo between rat serum protease inhibitors and anodal and cathodal rat trypsin and chymotrypsin.
    Gauthier F; Genell S; Mouray H; Ohlsson K
    Biochim Biophys Acta; 1979 Jan; 566(1):200-10. PubMed ID: 83164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uniform method for determining the alpha 1-antitrypsin and alpha 2-macroglobulin activity in human blood serum (plasma)].
    Nartikova VF; Paskhina TS
    Vopr Med Khim; 1979; 25(4):494-9. PubMed ID: 89758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiproteinase activity of alpha 2-macroglobulin].
    Protsenko AV
    Ukr Biokhim Zh (1978); 1984; 56(5):546-9. PubMed ID: 6209837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control.
    Finotti P; Piccoli A; Carraro P
    Diabetes Res Clin Pract; 1992 Oct; 18(1):35-42. PubMed ID: 1280191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of some proteinase inhibitors: alpha 1-antitrypsin and alpha 2-macroglobulin in rabbit blood serum in two models of experimental atherosclerosis.
    Grabowska-Bochenek R; Drózdz M; Kopieczna-Grzebieniak E; Piekarski M
    Acta Biochim Pol; 1990; 37(1):125-7. PubMed ID: 1708185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitors of proteolytic enzymes in the blood serum of patients with diphyllobothriasis].
    Gosteva LA
    Med Parazitol (Mosk); 1990; (4):29-31. PubMed ID: 1700263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
    Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
    Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proteinases, proteinase inhibitors and other selective plasma proteins following aortofemoral bypass operation.
    Hörl M; Sperling M; Mayer J; Hörl WH
    Eur Surg Res; 1986; 18(2):69-79. PubMed ID: 2423335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2 macroglobulin and the protease-inhibitory activity of colloid pancreatic preservation solutions.
    Donnelly PK; Edwards C; Condie R
    Transplant Proc; 1990 Apr; 22(2):535-6. PubMed ID: 1691543
    [No Abstract]   [Full Text] [Related]  

  • 19. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
    Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic enzyme activity in patients with severe head injury and the effect of a proteinase inhibitor.
    Auer LM; Marth E; Heppner F; Holasek A
    Acta Neurochir (Wien); 1979; 49(3-4):207-17. PubMed ID: 92877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.